Valproic Acid Syndrome: A Mini Review

Aims: To provide a systematic review on the occurrence of valproic acid syndrome, to, among others, elucidate characteristics this syndrome.
 Study Design: A was performed.
 Place and Duration Study: Laboratory Biomathematics Federal UINiversity Alfenas, Minas Gerais State, Brazil, between June 2022 July 2023.
 Methodology: search articles performed using CAPES Periodic plataform searcher from Education Ministry Brazil that contains Web Science, Scopus, MedLine other bases, 1984 to 2023. For review, subject’s “syndrome acid”, “valproic syndrome toxicity”, malformations” were searched together type material “articles” in English language. Some about “pregnancy’s cares” used for epistemological composition work content subjects as, instance, “general toxicity” “others (development; health care; …)”.
 Results: From 1061 after exclusion inclusion criteria made with most pertinent objectives work, added “pregnancy “others”; 1005 excluded, remaining 56 ones. Four total texts 4 toxicity”; 19 “Pregnancy 29 acid”.
 Conclusion: The analysis studied indicates is teratogen leads receives its name fetuses whose mothers use it as an anticonvulsant mood stabilizer primarily treating conditions like epilepsy bipolar disorder, causing several physical defects general behavioral due impairment neural system. In sense, essential team caring pregnant women know history woman check all medications she replace those teratogenic potential, especially if patient has diagnosis mental illness such depression.